{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T19:30:45Z","timestamp":1782847845771,"version":"3.54.5"},"reference-count":8,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T00:00:00Z","timestamp":1645747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Vascular"],"published-print":{"date-parts":[[2023,6]]},"abstract":"\n Objective<\/jats:title>\n Chronic venous insufficiency is a common vascular condition with significant resultant patient morbidity. There has been a shift towards minimally invasive treatment modalities with VenaSeal endovenous ablation among the more recent treatment modalities introduced. Long-term outcome data for this treatment modality is not widely available yet. We aim to report 6-week patient outcomes over a 5-year period from a high-volume tertiary vascular centre.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n This is a retrospective, single-centre study reporting short-term outcomes following VenaSeal endovenous ablation for symptomatic saphenous incompetence. Patients were followed-up at 6-weeks post-procedurally by telemedicine or in-person clinic appointment without routine venous ultrasound assessment.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n We report outcomes for 235 patients during this study period. All patients tolerated the procedure under local anaesthesia. Average age was 60.5\u00a0years (29\u201382\u00a0years) with slight male predominance (55.7%). The majority were New Zealand European (63.8%). Mean body mass index was 28.5 (22.2\u201341.4). We report a 21% rate of self-limiting phlebitis and 33 minor complication events. These include 15 cases of residual varicose veins, 9 saphenous nerve neuropraxia, 6 cases of puncture-site cellulitis and 3 deep vein thromboses. Patient demographics and primary surgeon did not have a statistically significant outcome on development of complications<\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n We report that VenaSeal endovenous ablation is a safe and effective method of treatment for symptomatic truncal saphenous vein incompetence. We report safely managing post-operative phlebitis conservatively and find a mixture of clinical and phone clinic follow-up sufficient without requirement for objective duplex ultrasound following the procedure to ensure objective saphenous vein closure.<\/jats:p>\n <\/jats:sec>","DOI":"10.1177\/17085381221077511","type":"journal-article","created":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T04:42:07Z","timestamp":1645764127000},"page":"521-525","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Real-world short-term VenaSeal ablation outcomes for symptomatic saphenous incompetence"],"prefix":"10.1177","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8127-8407","authenticated-orcid":false,"given":"Morwan","family":"Bahi","sequence":"first","affiliation":[{"name":"Department of Vascular Surgery, Wellington Regional Hospital, Wellington, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Guazzo","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, Royal Brisbane Hospital, Brisbane, QLD, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lupe","family":"Taumoepeau","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, Wellington Regional Hospital, Wellington, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2022,2,25]]},"reference":[{"key":"bibr1-17085381221077511","doi-asserted-by":"publisher","DOI":"10.1177\/0268355519885221"},{"key":"bibr2-17085381221077511","doi-asserted-by":"publisher","DOI":"10.1177\/0268355519864755"},{"key":"bibr3-17085381221077511","doi-asserted-by":"publisher","DOI":"10.1177\/0268355519826008"},{"key":"bibr4-17085381221077511","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvsv.2012.09.010"},{"key":"bibr5-17085381221077511","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvsv.2016.12.005"},{"key":"bibr6-17085381221077511","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvsv.2014.09.001"},{"key":"bibr7-17085381221077511","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvsv.2019.12.080"},{"issue":"5","key":"bibr8-17085381221077511","first-page":"1215","volume":"9","author":"O\u2019Banion LA","year":"2021","journal-title":"J Vasc Surg Ven Lymph Disord"}],"container-title":["Vascular"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17085381221077511","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/17085381221077511","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17085381221077511","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T07:36:34Z","timestamp":1777707394000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/17085381221077511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,25]]},"references-count":8,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["10.1177\/17085381221077511"],"URL":"https:\/\/doi.org\/10.1177\/17085381221077511","relation":{},"ISSN":["1708-5381","1708-539X"],"issn-type":[{"value":"1708-5381","type":"print"},{"value":"1708-539X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,25]]}}}